Endymed Ltd (ENDY.TA)
ILA 282.7
(-2.75%)
ILA 282.7
(-2.75%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 11.66 Million USD | 15.89% |
| 2022 | 10.06 Million USD | -0.84% |
| 2021 | 10.14 Million USD | 27.28% |
| 2020 | 7.97 Million USD | -18.63% |
| 2019 | 9.8 Million USD | -2.47% |
| 2018 | 10.04 Million ILS | 36.54% |
| 2017 | 7.35 Million ILS | -3.53% |
| 2016 | 7.62 Million ILS | 23.75% |
| 2015 | 6.16 Million USD | 17.54% |
| 2014 | 5.24 Million USD | 48.98% |
| 2013 | 3.52 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 2.52 Million USD | 25.97% |
| 2024 Q1 | 2 Million USD | -28.11% |
| 2023 Q2 | 2.94 Million USD | -16.19% |
| 2023 Q1 | 3.5 Million USD | 27.66% |
| 2023 Q4 | 2.78 Million USD | 14.61% |
| 2023 Q3 | 2.43 Million USD | -17.35% |
| 2023 FY | 11.66 Million USD | 15.89% |
| 2022 Q3 | 1.88 Million USD | -18.12% |
| 2022 FY | 10.06 Million USD | -0.84% |
| 2022 Q4 | 2.74 Million USD | 45.86% |
| 2022 Q2 | 2.3 Million USD | -26.51% |
| 2022 Q1 | 3.13 Million USD | 35.6% |
| 2021 Q4 | 2.3 Million USD | -8.7% |
| 2021 Q1 | 2.32 Million USD | 11.02% |
| 2021 Q2 | 2.98 Million USD | 28.73% |
| 2021 FY | 10.14 Million USD | 27.28% |
| 2021 Q3 | 2.52 Million USD | -15.39% |
| 2020 Q3 | 2.09 Million USD | 24.75% |
| 2020 Q1 | 1.67 Million USD | -31.68% |
| 2020 Q2 | 1.67 Million USD | 0.0% |
| 2020 Q4 | 2.09 Million USD | 0.0% |
| 2020 FY | 7.97 Million USD | -18.63% |
| 2019 Q2 | 3.01 Million ILS | 29.73% |
| 2019 Q3 | 2 Million ILS | -33.43% |
| 2019 FY | 9.8 Million USD | -2.47% |
| 2019 Q4 | 2.45 Million USD | 22.27% |
| 2019 Q1 | 2.32 Million ILS | -20.6% |
| 2018 Q1 | 2.45 Million ILS | 102.56% |
| 2018 FY | 10.04 Million ILS | 36.54% |
| 2018 Q4 | 2.92 Million ILS | 36.52% |
| 2018 Q3 | 2.14 Million ILS | -14.99% |
| 2018 Q2 | 2.52 Million ILS | 2.73% |
| 2017 Q2 | 2.07 Million USD | 7.84% |
| 2017 Q3 | 2.01 Million USD | -2.89% |
| 2017 Q4 | 1.21 Million USD | -39.88% |
| 2017 FY | 7.35 Million ILS | -3.53% |
| 2017 Q1 | 1.92 Million USD | -6.05% |
| 2016 Q2 | 1.58 Million USD | 7.95% |
| 2016 Q3 | 2.38 Million USD | 50.35% |
| 2016 FY | 7.62 Million ILS | 23.75% |
| 2016 Q4 | 2.04 Million USD | -14.23% |
| 2016 Q1 | 1.47 Million USD | 0.34% |
| 2015 FY | 6.16 Million USD | 17.54% |
| 2015 Q4 | 1.46 Million USD | 3.16% |
| 2015 Q3 | 1.42 Million USD | -22.97% |
| 2015 Q2 | 1.84 Million USD | 29.18% |
| 2015 Q1 | 1.42 Million USD | -17.87% |
| 2014 Q2 | 1.13 Million USD | 11.91% |
| 2014 Q1 | 1.01 Million USD | 4.73% |
| 2014 FY | 5.24 Million USD | 48.98% |
| 2014 Q4 | 1.74 Million USD | 19.26% |
| 2014 Q3 | 1.45 Million USD | 28.32% |
| 2013 FY | 3.52 Million USD | 0.0% |
| 2013 Q2 | 867.99 Thousand USD | 18.98% |
| 2013 Q3 | 999.29 Thousand USD | 15.13% |
| 2013 Q4 | 970.12 Thousand USD | -2.92% |
| 2013 Q1 | 729.5 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|